Form 4 for TARA Protara Therapeutics, Inc.
Accepted 2024-01-05 00:00:00 ET · period of report 2024-01-03 · accession 0001213900-24-001541 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-05 | 2024-01-03 | TARA | Shefferman Jesse | CEO, Pres, Dir | F - Tax | $2.17 | -5,840 | 898.6K | -0.6% | -$12.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-03 | F | D | 5,840 | $2.17 | 898,613 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022. |